Skip to content
Nootropic
Geek — Home
Home/Reviews/NADH Review: Cellular Energy and Fatigue Research
Review

NADH Review: Cellular Energy and Fatigue Research

Read the review ↓

Nootropic Geek is an affiliate publisher. Some links may earn us a commission. Disclosure · Editorial standards

NADH Review: Cellular Energy and Fatigue Research
Brain power

NADH Review: Cellular Energy and Fatigue Research

NADH is the reduced form of nicotinamide adenine dinucleotide, a coenzyme involved in energy metabolism. That biological role explains why researchers have studied it for fatigue. It does not mean an oral supplement acts as an on-switch for brain energy or that fatigue is evidence of an NADH deficiency.

The ATP connection

Cells use the NAD+/NADH pair in oxidation–reduction reactions. NADH carries electrons into processes involved in ATP production. ATP is needed for nerve signalling, muscle contraction and many other cellular tasks. These are important functions of normal physiology, but they do not establish how much orally supplemented NADH reaches a target tissue or whether a person will feel more alert.

NADH, NAD+, niacin and supplements marketed as NAD precursors are not interchangeable interventions. Evidence for one cannot simply be transferred to another. Similarly, laboratory observations about dopamine or oxidative stress do not demonstrate a clinical mood or memory benefit.

Chemical structure of Nicotinamide adenine dinucleotide (NADH).

The small NADH-alone fatigue trial

A placebo-controlled crossover pilot enrolled 26 people with chronic fatigue syndrome. Participants received 10 mg of stabilized oral NADH or placebo during four-week treatment periods separated by a washout. Eight participants responded favourably to NADH versus two to placebo.

That was an encouraging pilot result, but a small response count is not confirmation of an effective treatment, and participants with a diagnosed illness are not equivalent to healthy people seeking more productivity. The study amount describes the experiment; it is not a dose recommendation for unexplained tiredness.

Archived illustration accompanying NADH Review
By Muessig (Own work) [CC BY-SA 3.0], via Wikimedia Commons

Combination studies cannot isolate NADH

A later randomized study investigated CoQ10 plus NADH in people with ME/CFS. Because both substances were given together, the study cannot establish that NADH alone caused any change. It also matters whether a reported improvement was measured against baseline or against the placebo group: these are different comparisons.

The original article connected women, age-related NADH changes and chronic fatigue into a causal story. Those associations do not demonstrate that NADH depletion causes ME/CFS. The older dementia and depression observations likewise do not justify claims that NADH stops brain degeneration or treats depression.

What remains uncertain

The relevant questions are formulation, study population, duration, meaningful benefit and safety. An absence of serious adverse events in a small pilot does not establish universal or long-term safety. There is no established NADH regimen for cognitive enhancement in healthy adults.

Persistent fatigue, sleepiness or new cognitive difficulty deserves assessment for its cause. A supplement should not delay that assessment or replace established care. NADH is best described here as a biologically plausible but incompletely established fatigue intervention, with substantially weaker support for the archive’s broad memory, motivation and anti-aging claims.

Archived illustration accompanying NADH Review

Sources and further reading

Related reading

Nootropic Geek is an affiliate publishing brand. This ingredient review is an editorial assessment of published evidence, not a clinical consultation or a claim of hands-on product testing. About Nootropic Geek.

Continue exploring
More from Nootropic Geek

Related reading.